Pilot study assessing the use of cabergoline for the treatment of cats with hypersomatotropism and diabetes mellitus

ObjectivesAn affordable and effective treatment is needed to manage feline hypersomatotropism. The aim of this study was to assess whether treatment with oral cabergoline for 90 days in cats with hypersomatotropism and diabetes mellitus improved diabetic …